Urine Test Strips Global Market Report 2025

The urine test strips market size has grown strongly in recent years. It will grow from $1.93 billion in 2024 to $2.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%.

This growth during the historic period was driven by greater awareness of routine health assessments, increased healthcare spending, higher incidence of urinary tract infections, growing interest in personalized medicine, and a rise in transplant procedures.

The urine test strips market size is expected to see strong growth in the next few years. It will grow to $2.95 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%.

This anticipated growth is attributed to the rising burden of chronic illnesses, an expanding elderly population, growing focus on preventive care, increasing utilization of point-of-care diagnostics, and a surge in demand for at-home testing solutions. Notable trends projected for the forecast period include advancements in biosensor technology, integration with digital healthcare systems, emergence of smartphone-compatible testing kits, incorporation of IoT into diagnostic tools, and the evolution of strips capable of detecting multiple parameters simultaneously.

The growing prevalence of diabetes is anticipated to drive the expansion of the urine test strips market. Diabetes is a chronic disease characterized by the body’s inability to regulate blood sugar due to inadequate insulin production or resistance to insulin. The rise in diabetes cases is largely attributed to poor dietary habits and sedentary lifestyles. Urine test strips play a crucial role in diabetes management by detecting excess glucose or ketones in urine, signaling high blood sugar levels or the risk of complications. For example, in June 2023, the Institute for Health Metrics and Evaluation, a public health research institute based in the United States, reported that more than 500 million people globally were living with diabetes, a number projected to exceed 1.3 billion by 2050. As a result, the increasing diabetes prevalence is fueling the demand for urine test strips.

Leading companies in the urine test strip market are introducing innovative products such as at-home urine test strips to improve user convenience, promote preventive healthcare, provide real-time diagnostic insights, and cater to the demand for personalized wellness solutions. These at-home test strips allow individuals to assess their urine for various health indicators, including hydration, pH levels, and nutrient content, from their homes. For instance, in September 2024, Otsuka Pharmaceutical Co. Ltd., a pharmaceutical company based in Japan, collaborated with Vivosens Inc., a U.S.-based company, to bring the Vivoo nutrition tracking service to the Japanese market. This partnership merges Otsuka’s healthcare knowledge with Vivosens’s advanced technology to offer a unique wellness solution centered on at-home urine testing. Vivoo users can conduct a urine test at home and scan the strip using the Vivoo app, which leverages proprietary AI and image recognition to deliver real-time nutritional feedback. Based on the results, users receive personalized dietary and lifestyle guidance from professional nutritionists.

In March 2025, the National Kidney Foundation, a non-profit organization in the United States, formed a partnership with Healthy.io to enhance early detection and raise awareness of chronic kidney disease. The initiative provides free, at-home urine test kits that are easy to use and particularly accessible to marginalized and high-risk populations. Healthy.io, a health technology company based in the United Kingdom, specializes in converting traditional urine test strips into digital diagnostic tools using smartphone technology.

Major players in the urine test strips market are Cardinal Health Inc., F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Henry Schein Inc., Quidel Corporation, Sysmex Corporation, Beckman Coulter, Eiken Chemical Co. Ltd., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., MACHEREY-NAGEL GmbH & Co. KG, Acon Laboratories Inc., ARKRAY Inc., Teco Diagnostics, Clarity Diagnostics LLC, Analyticon Biotechnologies AG, and Bioway Biological Technology Co. Ltd.

Urine test strips, also known as dipsticks or urinalysis test strips, are diagnostic tools used to identify and measure different substances present in urine. These strips are typically composed of plastic and feature small pads or squares that contain chemically treated paper. Each pad is formulated to react with a particular compound in the urine, causing a color change that reflects the presence and/or concentration of that substance.

The primary categories of urine test strips include those for detecting proteins, hemoglobin, myoglobin, glucose, nitrites, and other components. Protein test strips are used to detect the presence of proteins such as albumin in urine, which can be a sign of kidney disorders, including nephritis or diabetic nephropathy. These strips are available in both visual and automated formats and are distributed through various channels such as online platforms, pharmacies, supermarkets, and hypermarkets. They are commonly used in the diagnosis of conditions like urinary tract infections, diabetes, liver disorders, and kidney diseases, as well as for pregnancy monitoring. End-users include research institutes, laboratories, hospitals, clinics, diagnostic centers, and individual users.

The urine test strips market research report is one of a series of new reports that provides urine test strips market statistics, including the urine test strips industry's global market size, regional shares, competitors with the urine test strips market share, detailed urine test strips market segments, market trends and opportunities, and any further data you may need to thrive in the urine test strips market. This urine test strips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

North America was the largest region in the urine test strips market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in urine test strips report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the urine test strips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The urine test strips market consists of sales of multi-parameter urinalysis strips, single-parameter strips, and specialized strips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.